Competing interests
treatment-resistant depression
Ms. Jamieson, Dr. Popova, Ms. Cooper, Dr. Drevets, and Dr. Rozjabek are employees of Janssen Research & Development, LLC and may hold company stock and/or stock options. Both Drs. Singh and Daly worked on the clinical development program of esketamine for treatment-resistant depression during their employment by Janssen Research & Development, LLC; Dr. Singh is currently employed by Neurocrine Biosciences, San Diego, CA; Dr. Daly is currently a self-employed medical consultant.